Navigation Links
TOFUTTI Announces First Quarter Results
Date:5/13/2008

s profit 1,527 1,696

Operating expenses 1,184 1,472

Income before income taxes 343 224

Income taxes 139 96

Net income $204 $128

Net income per common share:

Basic $0.04 $0.02

Diluted $0.03 $0.02

Weighted average common shares outstanding:

Basic 5,619 5,543

Diluted 5,869 5,813

TOFUTTI BRANDS INC.

Condensed Balance Sheets

(in thousands, except share figures)

March 29, December 29,

2008 2007

(unaudited)

Assets

Current assets:

Cash and cash equivalents $596 $1,499

Accounts receivable, net of allowance

for doubtful accounts and sales promotion

of $438 and $430, respectively 1,862 1,991

Inventories 2,162 1,552

Prepaid expenses 23 46

Refundable income taxes 635 770

Deferred income taxes 298 298

Total current assets 5,576 6,156

Fixed assets, net of accumulated

amortization of $20 and $19 23 24

Other assets
'/>"/>

SOURCE TOFUTTI BRANDS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. TOFUTTI Announces 2007 Results
2. Natural Alternatives International, Inc. Announces Third Quarter Results
3. eDiets.com(R) Announces Q1 2008 Results
4. Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
5. United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results
6. The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity
7. Aflac Announces Title Sponsorship of Outdoor Games
8. China Biologic Products Announces the Change of CEO and CFO
9. Medivation Announces Participation in Upcoming Conferences
10. China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
11. Good Feet Announces New Arch Support Product Line for Children Ages 6 and Older
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...eyed MCO Pharmacy Directors Will Move Razadyne and...zadyne is Launched, According to a New ... Mass., July 9 /PRNewswire/ -- Decision Resources,...firms for pharmaceutical and,healthcare issues, fi.../Ortho McNeil,s Razadyne (galantamine) in December...
(Date:7/9/2008)...ve day OnBase deployment critical in electronic he...t patients, CLEVELAND, July 9 /PRNewswire/ -- Hyl...e document management software suite, announced th...ts since the deployment of,OnBase in March. Based ...ur,states, SSM is a forward-thinking health care p...
(Date:7/9/2008)..., July 9 /PRNewswire-FirstCall/ - MDS Inc. (TSX: M... services to the global life,sciences markets, tod...anada Limited (AECL) with notice of arbitration pr...AECL to fulfill its contractual obligations,under ...LTSA) and if not,granted, seeking significant mone...
(Date:7/9/2008)... DRE, Inc., a premier international ...ts customers that as much as $250,000 in medical e...e tax filings. , Louisvil...us Act of 2008, in accordance with Tax Code Sectio...equipment bought in 2008. This could make 2008 an ...
Breaking Medicine News(10 mins):Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...s over the practice of "Breast Ironing" in West A...t and is used to stunt breast growth in girls by m...is for their own good. It is aimed at warding off...by hard or heated objects pressed against the deve...
...atment of breast cancer, researchers have discover...sue when standard chemotherapy is combined with a ...involved in causing cancer. In a multicenter clini...issue of the Journal of Clinical Oncology, women w...
... would exempt the millions of vulnerable Medicaid ... give proof of their citizenship// by showing pass...s move was mainly seen as an attempt to pre-empt a...led to hold a hearing on Friday on a lawsuit chall...
...re six new ways to fight HIV/AIDS in the next five... Malaysia said that the plan, which was approved ...er the 9th Malaysia Plan. “One of the strategies i... leadership, commitment and collaboration in fight...
Other Medicine News:Health News:Significant Advance in Treatment of Breast Cancer Reported 2Health News:Bush Administration to Exempt Medicaid Recipients on Proof of Citizenship 2
(Date:7/7/2008)...Newswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bull...ed biopharmaceutical,company specializing in the p...day provided an operational update on the company,...uman clinical trial testing and,plans to proceed i.... Five,successful human trials evaluating GeoVax A...
(Date:7/7/2008)...uly 7 /- Biopure Corporatio... discussions with the Food,and Drug Administration...tion for a new clinical trial of Hemopure(R) [hemo...ure has proposed to study use of Hemopure,in patie...) who refuse,transfusion with blood components. Cu...
(Date:7/7/2008)...ests Kiwifruit is Top Performer in the Body, SEAT...ated equal when,it comes to their antioxidant powe...bioavailability compared to other antioxidant-rich...published in the Journal of the,American College o...hytochemicals called flavonoids that,may have the ...
(Date:7/6/2008)...CTI,s Marketing Authorization Application currentl... SEATTLE, July 7 /- Cell T...y announced the publication of results from its,ra...litaxel poliglumex,CT-2103) with gemcitabine or v...status 2) patients with previously untreated non-s...
Breaking Medicine Technology:GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5UPMC and UPMC Health Plan Recognized Nationally for Quality Leadership in Employee Health and Productivity 4488 1UPMC and UPMC Health Plan Recognized Nationally for Quality Leadership in Employee Health and Productivity 4488 2UPMC and UPMC Health Plan Recognized Nationally for Quality Leadership in Employee Health and Productivity 4488 3Joint Juice Helps America Hydrate Its Joints With New High Value Coupon Offer 4486 1Joint Juice Helps America Hydrate Its Joints With New High Value Coupon Offer 4486 2Joint Juice Helps America Hydrate Its Joints With New High Value Coupon Offer 4486 3Twinkle After Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 4484 1Twinkle After Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 4484 2Twinkle After Effect Can Help Retinal Patients Detect Vision Loss Quickly and Cheaply and Prevent Further Loss 4484 3MSA Schedules Third Quarter Earnings Webcast 4482 1MSA Schedules Third Quarter Earnings Webcast 4482 2
... NEW YORK--(BUSINESS WIRE)--May 30, 2007 - INNOVIV...ced that interim data from a Phase I,trial of INNO...kinase inhibitor for Gleevec(R)-resistant or,treat... be,presented at the 43rd American Society of Clin...ace June 1- 5, 2007 at McCormick Place,in Chicago,...
... PALO ALTO, Calif., May 31, 2007 /PRNewswire-Firs...oday that it will present at the,49th Annual Ameri...e IIb clinical trial of Staccato(R) prochlorperazi...adache. The poster,presentation, "Efficacy and tol...zine) in patients with migraine headache",(Poster ...
Other Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2
...ecifically to enable direct inspection of the peri... applications as well. Its insertion tube and dist...nsertion into the peripheral bronchi can be accomp...ated scope offers high-resolution and brightness, ...
Double lumen tubes for selective one-lung ventilation., ,Each SHER-I-BRONCH Endobronchial Tube is packaged with pre-loaded stylet, tube-to-circuit adaptors, suction catheters and Accessories Pack (f
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. The set consists of an endobronchial blocker catheter and an Arndt Multiport Airway Adapte
...tablish emergency airway access through the cricot...s a 12 gauge x 3" Angiocath I.V. catheter, which i...to ventilate. Designed to be used with the liter f...milar to the Cook Emergency Cricothyrotomy Kit, bu...
Medicine Products: